Virtual | Virtual
Event Title
Finding Your Support Team While Participating in a Clinical Trial
October 30, 2024
- Date:
- October 30, 2024
- Time:
- 12:00 PM - 1:15 PM ET
The FDA’s Center for Biologics Evaluation and Research (CBER), Office of Therapeutic Products (OTP) is hosting a public virtual webinar on Wednesday, October 30th from 12:00 p.m. – 1:15 p.m. ET. The webinar, Finding Your Support Team While Participating in a Clinical Trial, will feature patients, care partners, and advocates who have direct experience building and managing support networks while navigating and participating in clinical trials. Speakers for this webinar have experience with clinical trials for regenerative medicine products, such as cell and gene therapies. However, all are welcome to attend as this information may be helpful for many patients and their care partners.
Focus for this RegenMedEd Webinar
There are many factors that may impact a patient’s decision to participate in a clinical trial. Clinical trials may involve travel to medical centers, requiring participants to take time off work or school. Additionally, patients may need support getting to and from appointments, scheduling appointments, tracking symptoms, managing day-to-day tasks, and more. Friends, family members, colleagues, and others can serve as support for patients as they take part in these studies.
The webinar will feature a panel of patients, care partners, and advocates to share and discuss:
- Experiences with their own support systems as they or a loved one participated in a clinical trial.
- Tips on how to navigate logistical challenges, such as travel and finances, when participating in a clinical trial.
- Where and how to find support from friends and family, health care providers, clinical teams, employers, schools, patient advocacy groups, and other communities.
Meeting Information & Registration
This event is free and open to the public. However, registration is required.
- Date: Wednesday, October 30th, 2024
- Time: 12:00 p.m. – 1:15 p.m. ET
- Location: The webinar will be held via Zoom.
- Please register for the webinar now.
- Ask Us a Question: Registrants can submit questions for speakers on the registration page and during the event.
- Get Involved: Use the hashtag #RegenMedEd on social media to share this event with your network.
What is Regenerative Medicine?
Regenerative medicine therapies, such as cell and gene therapies, hold promise for transforming medicine and creating options for patients living with difficult, rare, and often incurable diseases. The FDA plays a vital role in facilitating the development of regenerative medicine therapies, as well as in ensuring approved products are safe and effective for patients.
About the RegenMedEd Series
This webinar is part of an educational series, RegenMedEd: An FDA CBER OTP Series on Regenerative Medicine. The RegenMedEd series aims to provide foundational information about regenerative medicine therapies, such as gene and cell therapy products, and explore opportunities for patients, care partners, and advocates to engage with FDA to help advance product development of OTP-regulated products.
You can access previous RegenMedEd event materials, including event recordings and transcripts, on FDA.gov.